Where does ICU stock trade?

SeaStar Medical Holding Corporation (ICU) is listed on NASDAQ.

What sector and industry is ICU in?

SeaStar Medical Holding Corporation operates in the Health Care sector, Medical/Dental Instruments industry.

When did SeaStar Medical Holding Corporation go public?

SeaStar Medical Holding Corporation (ICU) completed its IPO in 2021.

What companies are similar to ICU?

Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare ICU side-by-side with any of them on Quantisnow.

How can I track ICU on Quantisnow?

Quantisnow aggregates SeaStar Medical Holding Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ICU to receive live email and push alerts on every new disclosure.

ICU

NASDAQ

SeaStar Medical Holding Corporation

SectorHealth CareIndustryMedical/Dental InstrumentsIPO2021

$4.05-0.22 (-5.15%)

News25/Ratings0

Price$4.05-0.18 (-4.26%)

02:45 PM06:30 PM

News · 26 weeks49+100%

2026-01-252026-07-19

Mix3090d

SEC Filings14(47%)
Other9(30%)
Insider6(20%)
Earnings1(3%)

Latest news

25 items

4dPR
SeaStar Medical Supports Advances in Critical Care of Pediatric Patients with Acute Kidney Injury (AKI)
Sponsors educational summit of leading pediatric AKI health care experts Announces best practices webinar to further advance new treatment options DENVER, July 14, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that it is a proud sponsor of key initiatives to advance the treatment of pediatric patients with acute kidney injury (AKI). AKI is a major driver of critical illness, prolonged hospital stays, and high mortality rates. Despite its massive impact on patient outcomes, significant gap
16dINSIDER
Chief Executive Officer Schlorff Eric was granted 10,288 shares, increasing direct ownership by 26% to 50,140 units (SEC Form 4)
4 - SeaStar Medical Holding Corp (0001831868) (Issuer)
16dINSIDER
Chief Medical Officer Chung Kevin was granted 7,202 shares, increasing direct ownership by 35% to 28,021 units (SEC Form 4)
4 - SeaStar Medical Holding Corp (0001831868) (Issuer)
16dINSIDER
Director Vincent Bernadette N was granted 4,000 shares, increasing direct ownership by 95% to 8,200 units (SEC Form 4)
4 - SeaStar Medical Holding Corp (0001831868) (Issuer)
16dINSIDER
Director Neuman John was granted 4,000 shares, increasing direct ownership by 33% to 16,200 units (SEC Form 4)
4 - SeaStar Medical Holding Corp (0001831868) (Issuer)
16dINSIDER
Director Van Heel Kenneth was granted 4,000 shares, increasing direct ownership by 50% to 11,940 units (SEC Form 4)
4 - SeaStar Medical Holding Corp (0001831868) (Issuer)
16dINSIDER
Director Baird Jennifer A was granted 4,000 shares, increasing direct ownership by 60% to 10,620 units (SEC Form 4)
4 - SeaStar Medical Holding Corp (0001831868) (Issuer)
17dSEC
SeaStar Medical Holding Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
25dSEC
Amendment: SeaStar Medical Holding Corporation filed SEC Form 8-K: Leadership Update
8-K/A - SeaStar Medical Holding Corp (0001831868) (Filer)
25dPR
SeaStar Medical Announces New ICD-10-PCS Codes for Its SCD Therapy for Acute Kidney Injury
Enables standardized inpatient hospital billing for QUELIMMUNE® (SCD-PED) therapy Universal code paves the way for billing of future potential SCD therapies requiring renal replacement therapy DENVER, June 23, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life announced today that its Selective Cytopheretic Device (SCD) therapy has received dedicated ICD-10-PCS (International Classification of Diseases, 10th Revision, Procedure Coding System) codes from the Centers for Medicare & Medicaid Services (CMS). This assi
26dPR
SeaStar Medical to Present at Upcoming Investor Summit Conference
DENVER, June 22, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of life, announced today that Eric Schlorff, Chief Executive Officer of SeaStar Medical, will present at the Virtual Investor Summit Conference on Wednesday, June 24th at 10:30 am Eastern Time. Interested investors can register and view the live presentation here: SeaStar Medical Events / Presentations A replay of the SeaStar Medical presentation will be available on the Company's website and can be accessed here. The replay will be available for up to 30
31dSEC
SeaStar Medical Holding Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
66dSEC
SEC Form 424B3 filed by SeaStar Medical Holding Corporation
424B3 - SeaStar Medical Holding Corp (0001831868) (Filer)
66dSEC
SEC Form 10-Q filed by SeaStar Medical Holding Corporation
10-Q - SeaStar Medical Holding Corp (0001831868) (Filer)
66dSEC
Amendment: SEC Form SCHEDULE 13G/A filed by SeaStar Medical Holding Corporation
SCHEDULE 13G/A - SeaStar Medical Holding Corp (0001831868) (Subject)
66dSEC
SeaStar Medical Holding Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - SeaStar Medical Holding Corp (0001831868) (Filer)
66dPR
SeaStar Medical Reports First Quarter Financial Results and Provides Business Updates
Added 7 top-rated children's hospitals to QUELIMMUNE® pediatric acute kidney injury (AKI) customer base, increasing first quarter revenue 69% versus first quarter 2025 revenue Advanced enrollment in the NEUTRALIZE-AKI pivotal clinical trial in adult patients with AKI Initiated efforts for the submission of a modular post-marketing application (PMA) Webcast today at 4:30 pm Eastern Time DENVER, May 13, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced today financial results for the three months ended Marc
67dSEC
SEC Form EFFECT filed by SeaStar Medical Holding Corporation
EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
68dSEC
SEC Form SCHEDULE 13G filed by SeaStar Medical Holding Corporation
SCHEDULE 13G - SeaStar Medical Holding Corp (0001831868) (Subject)
72dSEC
Amendment: SEC Form S-1/A filed by SeaStar Medical Holding Corporation
S-1/A - SeaStar Medical Holding Corp (0001831868) (Filer)
73dPR
SeaStar Medical to Report First Quarter Financial Results on May 13, 2026
DENVER, May 06, 2026 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (NASDAQ:ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, announced today that it will report its first quarter financial results after market close on Wednesday, May 13, 2026, and host a webcast and conference call to discuss its financial results and business progress. Date/Time:Wednesday, May 13, 2026, at 4:30 p.m. ET / 2:30 p.m. MT Webcast:The live webcast and replay can be found here. Register for the call:Preregistration is required to attend the live call and can be accessed here. A pin code and dial i
73dSEC
SEC Form EFFECT filed by SeaStar Medical Holding Corporation
EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
73dSEC
SEC Form EFFECT filed by SeaStar Medical Holding Corporation
EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
73dSEC
SEC Form EFFECT filed by SeaStar Medical Holding Corporation
EFFECT - SeaStar Medical Holding Corp (0001831868) (Filer)
80dSEC
SEC Form DEF 14A filed by SeaStar Medical Holding Corporation
DEF 14A - SeaStar Medical Holding Corp (0001831868) (Filer)

ICU FAQ

5 questions

Where does ICU stock trade?
SeaStar Medical Holding Corporation (ICU) is listed on NASDAQ.
What sector and industry is ICU in?
SeaStar Medical Holding Corporation operates in the Health Care sector, Medical/Dental Instruments industry.
When did SeaStar Medical Holding Corporation go public?
SeaStar Medical Holding Corporation (ICU) completed its IPO in 2021.
What companies are similar to ICU?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare ICU side-by-side with any of them on Quantisnow.
How can I track ICU on Quantisnow?
Quantisnow aggregates SeaStar Medical Holding Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ICU to receive live email and push alerts on every new disclosure.